These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 25613139)
41. The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders. Marker DF; Tremblay MÈ; Puccini JM; Barbieri J; Gantz Marker MA; Loweth CJ; Muly EC; Lu SM; Goodfellow VS; Dewhurst S; Gelbard HA J Neurosci; 2013 Jun; 33(24):9998-10010. PubMed ID: 23761895 [TBL] [Abstract][Full Text] [Related]
42. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes. Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS Neurobiol Dis; 2012 Feb; 45(2):657-70. PubMed ID: 22036626 [TBL] [Abstract][Full Text] [Related]
43. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. Fields J; Dumaop W; Eleuteri S; Campos S; Serger E; Trejo M; Kosberg K; Adame A; Spencer B; Rockenstein E; He JJ; Masliah E J Neurosci; 2015 Feb; 35(5):1921-38. PubMed ID: 25653352 [TBL] [Abstract][Full Text] [Related]
44. Novel insights into role of miR-320a-VDAC1 axis in astrocyte-mediated neuronal damage in neuroAIDS. Fatima M; Prajapati B; Saleem K; Kumari R; Mohindar Singh Singal C; Seth P Glia; 2017 Feb; 65(2):250-263. PubMed ID: 27761954 [TBL] [Abstract][Full Text] [Related]
45. Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replication. Rodríguez-Mora S; Mateos E; Moran M; Martín MÁ; López JA; Calvo E; Terrón MC; Luque D; Muriaux D; Alcamí J; Coiras M; López-Huertas MR Retrovirology; 2015 Sep; 12():78. PubMed ID: 26376973 [TBL] [Abstract][Full Text] [Related]
46. Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. Silva C; Zhang K; Tsutsui S; Holden JK; Gill MJ; Power C Ann Neurol; 2003 Nov; 54(5):605-14. PubMed ID: 14595650 [TBL] [Abstract][Full Text] [Related]
47. Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Flora G; Lee YW; Nath A; Hennig B; Maragos W; Toborek M Exp Neurol; 2003 Jan; 179(1):60-70. PubMed ID: 12504868 [TBL] [Abstract][Full Text] [Related]
48. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Zhou BY; Liu Y; Kim Bo; Xiao Y; He JJ Mol Cell Neurosci; 2004 Nov; 27(3):296-305. PubMed ID: 15519244 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of HIV-1 tat-induced transactivation and apoptosis by the divalent metal chelators, fusaric acid and picolinic acid-implications for HIV-1 dementia. Ramautar A; Mabandla M; Blackburn J; Daniels WM Neurosci Res; 2012 Sep; 74(1):59-63. PubMed ID: 22698778 [TBL] [Abstract][Full Text] [Related]
50. Astrocytes mediate HIV-1 Tat-induced neuronal damage via ligand-gated ion channel P2X7R. Tewari M; Monika ; Varghse RK; Menon M; Seth P J Neurochem; 2015 Feb; 132(4):464-76. PubMed ID: 25272052 [TBL] [Abstract][Full Text] [Related]
51. A GluN2B-Selective NMDAR Antagonist Reverses Synapse Loss and Cognitive Impairment Produced by the HIV-1 Protein Tat. Raybuck JD; Hargus NJ; Thayer SA J Neurosci; 2017 Aug; 37(33):7837-7847. PubMed ID: 28716964 [TBL] [Abstract][Full Text] [Related]
52. HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific. Miller DR; Shaerzadeh F; Phan L; Sharif N; Gamble-George J; McLaughlin JP; Streit WJ; Khoshbouei H Glia; 2018 Sep; 66(9):1915-1928. PubMed ID: 29733459 [TBL] [Abstract][Full Text] [Related]